FR2926079B1 - PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF - Google Patents

PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF

Info

Publication number
FR2926079B1
FR2926079B1 FR0850014A FR0850014A FR2926079B1 FR 2926079 B1 FR2926079 B1 FR 2926079B1 FR 0850014 A FR0850014 A FR 0850014A FR 0850014 A FR0850014 A FR 0850014A FR 2926079 B1 FR2926079 B1 FR 2926079B1
Authority
FR
France
Prior art keywords
derivative
brand
preparing
purine
purine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0850014A
Other languages
French (fr)
Other versions
FR2926079A1 (en
Inventor
Louisa Barre
Patrice Marchand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0850014A priority Critical patent/FR2926079B1/en
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to JP2010541053A priority patent/JP5715823B2/en
Priority to ES08869353.6T priority patent/ES2654528T3/en
Priority to PCT/EP2008/068244 priority patent/WO2009087066A2/en
Priority to US12/810,965 priority patent/US20100290990A1/en
Priority to DK08869353.6T priority patent/DK2238139T3/en
Priority to CA2710900A priority patent/CA2710900C/en
Priority to EP08869353.6A priority patent/EP2238139B1/en
Publication of FR2926079A1 publication Critical patent/FR2926079A1/en
Application granted granted Critical
Publication of FR2926079B1 publication Critical patent/FR2926079B1/en
Priority to US14/633,067 priority patent/US11298432B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0850014A 2008-01-03 2008-01-03 PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF Expired - Fee Related FR2926079B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0850014A FR2926079B1 (en) 2008-01-03 2008-01-03 PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF
ES08869353.6T ES2654528T3 (en) 2008-01-03 2008-12-23 Procedure for preparing a labeled purine derivative, said derivative and its uses
PCT/EP2008/068244 WO2009087066A2 (en) 2008-01-03 2008-12-23 Method for preparing a marked purine derivative, said derivative and uses thereof
US12/810,965 US20100290990A1 (en) 2008-01-03 2008-12-23 Method for preparing a marked purine derivative, said derivative and uses thereof
JP2010541053A JP5715823B2 (en) 2008-01-03 2008-12-23 Method for producing marked purine derivatives, the purine derivatives, and uses thereof
DK08869353.6T DK2238139T3 (en) 2008-01-03 2008-12-23 Process for the preparation of a labeled purine derivative, this derivative and its use
CA2710900A CA2710900C (en) 2008-01-03 2008-12-23 Method for preparing a marked purine derivative, said derivative and uses thereof
EP08869353.6A EP2238139B1 (en) 2008-01-03 2008-12-23 Method for preparing a marked purine derivative, said derivative and uses thereof
US14/633,067 US11298432B2 (en) 2008-01-03 2015-02-26 Method for preparing a marked purine derivative, said derivative and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0850014A FR2926079B1 (en) 2008-01-03 2008-01-03 PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF

Publications (2)

Publication Number Publication Date
FR2926079A1 FR2926079A1 (en) 2009-07-10
FR2926079B1 true FR2926079B1 (en) 2012-12-28

Family

ID=39760970

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0850014A Expired - Fee Related FR2926079B1 (en) 2008-01-03 2008-01-03 PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF

Country Status (8)

Country Link
US (2) US20100290990A1 (en)
EP (1) EP2238139B1 (en)
JP (1) JP5715823B2 (en)
CA (1) CA2710900C (en)
DK (1) DK2238139T3 (en)
ES (1) ES2654528T3 (en)
FR (1) FR2926079B1 (en)
WO (1) WO2009087066A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
CN103333215A (en) * 2013-07-01 2013-10-02 淮海工学院 Synthetic method of 2-fluoroadenosine
FR3033359B1 (en) 2015-03-02 2017-04-07 Snecma MONOBLOC DRAWING DISK HAVING A HUB HAVING AN EVIDENCE FACED BY A BODY COMPRISING SAME
CN105237602B (en) * 2015-06-25 2018-05-18 新乡学院 A kind of preparation method of 2- amino arabinosy ladenosine
FR3055558B1 (en) 2016-09-08 2022-01-14 Commissariat Energie Atomique SOLID NANOCOMPOSITE MATERIAL BASED ON HEXA- OR OCTACYANOMETALLATES OF ALKALINE METALS, METHOD FOR PREPARING IT, AND METHOD FOR EXTRACTION OF METALLIC CATIONS.
CN107556356B (en) * 2017-09-27 2020-07-10 新乡拓新药业股份有限公司 Method for synthesizing vidarabine
CN110615818B (en) * 2019-09-27 2023-02-17 江西科技师范大学 Synthesis method of fludarabine and nelarabine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
KR19990064310A (en) * 1995-10-17 1999-07-26 윌리암스 로저 에이 Detection method of cyclooxygenase-2
US6126917A (en) * 1999-06-01 2000-10-03 Hadasit Medical Research Services And Development Ltd. Epidermal growth factor receptor binding compounds for positron emission tomography
WO2003099342A1 (en) 2002-05-22 2003-12-04 Abraham Edward H Labeled adenosine for use in positron emission tomography
FR2841554B1 (en) * 2002-07-01 2008-01-18 Commissariat Energie Atomique COMPOUNDS OF MALEIMIDES BRANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR MARKING MACROMOLECULES
US20050106101A1 (en) * 2003-10-31 2005-05-19 Ajay Purohit Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
KR20060125830A (en) 2003-12-05 2006-12-06 캠브리지 바이오테크놀로지 리미티드 Improved synthesis of 2-substituted adenosines
MXPA06009634A (en) 2004-02-24 2007-04-23 Gen Hospital Corp Catalytic radiofluorination.
JP4738419B2 (en) * 2005-11-30 2011-08-03 富士フイルムＲｉファーマ株式会社 Diagnostic and therapeutic agents for diseases caused by amyloid aggregation and / or deposition
KR20090093992A (en) * 2006-12-21 2009-09-02 해머스미쓰 이마네트 리미티드 Nucleophilic radiofluorination using microfabricated devices
EP2200658B1 (en) * 2007-09-19 2014-12-03 The Regents of The University of California Positron emission tomography probes for imaging immune activation and selected cancers

Also Published As

Publication number Publication date
US20150238640A1 (en) 2015-08-27
WO2009087066A2 (en) 2009-07-16
EP2238139A2 (en) 2010-10-13
CA2710900C (en) 2016-01-26
DK2238139T3 (en) 2018-01-08
FR2926079A1 (en) 2009-07-10
JP2011508752A (en) 2011-03-17
EP2238139B1 (en) 2017-09-27
US20100290990A1 (en) 2010-11-18
WO2009087066A3 (en) 2009-11-12
CA2710900A1 (en) 2009-07-16
ES2654528T3 (en) 2018-02-14
US11298432B2 (en) 2022-04-12
JP5715823B2 (en) 2015-05-13

Similar Documents

Publication Publication Date Title
FR2926079B1 (en) PROCESS FOR PREPARING A BRAND PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF
BRPI0912063A2 (en) "Method for preparing a lenticular imaging article, lenticular imaging article and system for preparing a lenticular imaging article"
IL242665B (en) A process for producing anti-tricyclo[3.2.2.0]non-6-ene-endo-8,endo-9-dicarboxylic acid anhydride
FR2945293B1 (en) PROCESS FOR PREPARING A RETICULATED GEL
BRPI0816439A2 (en) DISPENSING SYSTEM, AND METHOD FOR PREPARING A PRODUCT
ZA201004180B (en) Method for producing regenerated biopolymers and regenerated products obtained by said method
EP2341040A4 (en) Process for producing 1,3,3,3-tetrafluoropropene
EP2343101A4 (en) Stamper for microneedle sheet, method for manufacturing the stamper, and method for manufacturing microneedle using the stamper
PL2292574T3 (en) Process for producing 2,3,3,3-tetrafluoropropene
IL200444A0 (en) Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
ZA201005118B (en) Aqueous polymer dispersions,method for the production and use thereof
EP2216015A4 (en) Poorly soluble substance-surfactant complex product, and process for production thereof
MA31149B1 (en) A new method for the preparation of functional benzocyclopeptin, applied in the synthesis of ivabradine and additional salts to an acceptable pharmacist acid.
BRPI0815783A2 (en) PROCESS FOR PREPARING 1,2-PROPANODIOL.
FR2920775B1 (en) NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, PROCESS FOR PREPARING THEM AND USES THEREOF.
BRPI0905790A2 (en) microparticle, method for microparticle manufacture and pharmaceutical preparation
FR2929282B1 (en) FUNCTIONALIZED POLYSILOXANES, PROCESS FOR THEIR PREPARATION AND USES THEREOF
FR2943559B1 (en) AUTOSUPPORTED DYNAMIC POLYMERIC MEMBRANE, PROCESS FOR PREPARATION AND USE.
EP2119953A4 (en) Absorbent for spray can, process for producing absorbent sheet for spray can, and spray can product
FR2933303B1 (en) BONE SUBSTITUTE, AND PROCESS FOR PREPARING THE SAME
FR2921284B1 (en) PROCESS FOR RECOVERING TURBOMACHINE ELEMENTS
BRPI0815690A2 (en) METHODS FOR PRODUCING SUCCINIC ACID, AND FOR PRODUCING A POLYMER CONTAINING SUCCINIC ACID.
FR2934962B1 (en) ZEOLITHIC CATALYSTS, PROCESS FOR PREPARING SAME AND APPLICATIONS THEREOF
FR2957225B1 (en) PROCESS FOR THE ELEVATION OF SHELLAGES, IN PARTICULAR OYSTERS
FR2936129B1 (en) PRODUCT COMPRISING DIAMIDES, PROCESS FOR PREPARATION AND USES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20190906